Stoke Therapeutics Inc (STOK)
14.41
-0.30
(-2.04%)
USD |
NASDAQ |
May 24, 16:00
15.13
+0.72
(+5.00%)
After-Hours: 20:00
Stoke Therapeutics 1 Year Total Returns (Daily): 30.64% for May 24, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 24, 2024 | 30.64% |
May 23, 2024 | 23.61% |
May 22, 2024 | 39.91% |
May 21, 2024 | 36.81% |
May 20, 2024 | 43.49% |
May 17, 2024 | 23.34% |
May 16, 2024 | 25.04% |
May 15, 2024 | 20.36% |
May 14, 2024 | 11.89% |
May 13, 2024 | 0.96% |
May 10, 2024 | -1.46% |
May 09, 2024 | -1.23% |
May 08, 2024 | -3.65% |
May 07, 2024 | -0.08% |
May 06, 2024 | -0.67% |
May 03, 2024 | 26.66% |
May 02, 2024 | 18.80% |
May 01, 2024 | 17.12% |
April 30, 2024 | 24.07% |
April 29, 2024 | 33.41% |
April 26, 2024 | 38.35% |
April 25, 2024 | 44.14% |
April 24, 2024 | 43.95% |
April 23, 2024 | 29.61% |
April 22, 2024 | 29.61% |
Date | Value |
---|---|
April 19, 2024 | 33.74% |
April 18, 2024 | 35.31% |
April 17, 2024 | 29.65% |
April 16, 2024 | 52.39% |
April 15, 2024 | 49.45% |
April 12, 2024 | 58.83% |
April 11, 2024 | 66.87% |
April 10, 2024 | 60.91% |
April 09, 2024 | 61.43% |
April 08, 2024 | 63.32% |
April 05, 2024 | 58.31% |
April 04, 2024 | 51.37% |
April 03, 2024 | 55.90% |
April 02, 2024 | 57.02% |
April 01, 2024 | 61.94% |
March 28, 2024 | 68.12% |
March 27, 2024 | 77.57% |
March 26, 2024 | 34.51% |
March 25, 2024 | -15.03% |
March 22, 2024 | -21.15% |
March 21, 2024 | -27.83% |
March 20, 2024 | -26.68% |
March 19, 2024 | -34.98% |
March 18, 2024 | -31.84% |
March 15, 2024 | -30.16% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-78.27%
Minimum
Oct 27 2023
200.3%
Maximum
Mar 16 2021
-12.60%
Average
-36.62%
Median
1 Year Total Returns (Daily) Benchmarks
NeuBase Therapeutics Inc | -90.49% |
iBio Inc | -87.21% |
Actinium Pharmaceuticals Inc | 0.71% |
Lixte Biotechnology Holdings Inc | -65.25% |
Fate Therapeutics Inc | -34.08% |